Anees B. Chagpar

Learn More
HYPOTHESIS Subareolar or periareolar injection of radioactive technetium sulfur colloid is equivalent to other injection techniques for breast cancer sentinel lymph node (SLN) biopsy. DESIGN AND SETTING Prospective, multicenter clinical trial. PATIENTS A total of 3961 individuals with clinical stage I and II breast cancer. INTERVENTIONS All patients(More)
Background. Prior studies have shown earlier recurrence and decreased survival in patients with head and neck cancer who smoked while undergoing radiation therapy. The purpose of the current study was to determine whether smoking status at the time of partial mastectomy and radiation therapy for breast cancer affected recurrence or survival. Method. A(More)
BACKGROUND It is known that cancer may affect patients' emotions and their relationships with other people and that those with strong emotional support may enjoy improved outcomes. We sought to determine the frequency with which healthcare professionals discuss the impact of cancer on patients' emotions and relationships with others. METHODS Data(More)
Tumor-infiltrating lymphocyte (TIL) count in breast cancer carries prognostic information and represents a potential predictive marker for emerging immunotherapies. However, the distribution of the lymphocyte subpopulations is not well defined. The goals of this study were to examine intratumor heterogeneity in TIL subpopulation counts in different fields(More)
INTRODUCTION Breast cancer is frequently diagnosed, yet variation remains in terms of practice patterns in presurgical workup. We sought to determine factors associated with this variation. METHODS An anonymous web-based survey was distributed to surgeons regarding their practices. Statistical analyses were conducted using SPSS. RESULTS A total of 253(More)
The aim of this study was to determine the features of triple-negative breast cancer (TNBC) using a large national database. TNBC is known to be an aggressive subtype, but national epidemiologic data are sparse. All patients with invasive breast cancer and known molecular subtype diagnosed in 2010 to 2011 were identified from the National Cancer Data Base(More)
The momentum in the Phase I Team has continued to climb since Pat joined us last August, and I am pleased to announce that our senior leadership team has appointed her to the position of Translational Working Group (TWG) Leader for the Phase I group, effective today. In this role, she will continue to work with Paul Eder, Clinical Program Leader for Phase(More)
BACKGROUND Little is known about the cost to Medicare of breast cancer screening or whether regional-level screening expenditures are associated with cancer stage at diagnosis or treatment costs, particularly because newer breast cancer screening technologies, like digital mammography and computer-aided detection (CAD), have diffused into the care of older(More)
  • 1